India may get 100 million doses of AstraZeneca's COVID-19 vaccine by Dec 2020
AstraZeneca`s COVID-19 vaccine will likely get 100 million doses ready by December for a vaccination drive across India, a Bloomberg report stated.
Nov 14, 2020, 12:53 PM IST
AstraZeneca COVID-19 vaccine trial volunteer in Brazil dies
Brazilian health authority Anvisa said on Wednesday that a volunteer in a clinical trial of the COVID-19 vaccine developed by AstraZeneca and Oxford University had died but added that the trial would continue.
Oct 22, 2020, 08:35 AM IST
Oxford’s coronavirus vaccine AstraZeneca resumes trial after clearance from UK health regulator
The phase I trial in healthy adult volunteers began in April 2020 and more than 1,000 immunisations were given in the UK.
Sep 12, 2020, 23:06 PM IST
DCGI suspends Serum Institute's phase 2, 3 clinical trials of AstraZeneca's COVID-19 vaccine
The Drugs Controller General of India (DCGI) Dr VG Somani on Friday ordered the pharma giant Serum Institute of India (SII) to suspend any new recruitment in phase 2 and 3 clinical trials for COVID-19 vaccine till further orders.
Sep 12, 2020, 08:12 AM IST
British drugmaker AstraZeneca expects COVID vaccine result by year-end if trials resume
Governments desperate to put an end to the COVID-19 pandemic which has caused more than 900,000 deaths and huge economic and social disruption during 2020 are pinning their hopes on a vaccine.
Sep 10, 2020, 23:38 PM IST
AstraZeneca Pharma shares tumble over 3%, company halts coronavirus vaccine trial after volunteer develops ‘unexpected’ illness
The company's stock had tumbled 13.40 percent to Rs 3,650 during the day on the BSE.
Sep 09, 2020, 17:55 PM IST
AstraZeneca halts coronavirus vaccine trial after volunteer develops ‘unexpected’ illness
In a significant development, pharmaceutical company AstraZeneca on Tuesday (September 8) said that it “voluntarily paused” the phase 3 clinical human trials of its vaccine candidate ‘Covishield’ after one of the volunteers got ill. It is to be noted that AstraZeneca is developing this vaccine in collaboration with University of Oxford.
Sep 09, 2020, 10:50 AM IST
Oxford vaccine's Phase 2 human trial may start at Pune hospital from August 26
The trial may begin from Wednesday, said a top official of the institute, one of the 17 sites selected for the phase 2 human trials in the country by Serum Institute of India (SII).
Aug 25, 2020, 22:44 PM IST
AstraZeneca-Oxford University coronavirus COVID-19 vaccine shows promising results after first human trial
"There is still much work to be done before we can confirm if our vaccine will help manage the COVID-19 pandemic, but these early results hold promise," vaccine developer Sarah Gilbert said.
Jul 20, 2020, 20:12 PM IST
634 drugs on NPPA's price ceiling non-compliant list
As many as 634 drugs of various strengths produced by firms, including Cipla, Abbott, Astrazeneca and Dr Reddy's, are "suspected" to be non-compliant with ceiling prices as notified by NPPA.
Feb 23, 2017, 23:33 PM IST
AstraZeneca-Ranbaxy drug settlement not anti-competitive
In a landmark judgement for pharma sector, a US jury has ruled that AstraZeneca's patent litigation settlement for blockbuster drug Nexium with Ranbaxy was not anti-competitive.
Dec 06, 2014, 22:57 PM IST
AstraZeneca, Ranbaxy prevail in Nexium antitrust trial
The US Federal Trade Commission estimates that pay-for-delay deals, in which a branded drugmaker pays a generic rival to stay off the market, cost consumers $3.5 billion each year.
Dec 06, 2014, 08:43 AM IST
US court overturns bid by Ranbaxy to block launch of rival generic drugs
A US court has denied a request by drugmaker Ranbaxy Laboratories Ltd to stop competitors from launching copies of AstraZeneca Plc`s heartburn pill Nexium and Roche`s antiviral Valcyte.
Nov 20, 2014, 11:06 AM IST
Pfizer's $11 billion buyback plan deflates AstraZeneca bid hopes
US drugmaker Pfizer is to continue buying back stock, with the board authorising a new $11 billion share repurchase plan, deflating expectations that it will make a new bid for AstraZeneca.
Oct 24, 2014, 18:30 PM IST
AstraZeneca smashes forecasts in Q2 after seeing off Pfizer
AstraZeneca smashed forecasts for second-quarter sales and earnings on Thursday, demonstrating resilience after seeing off a USD 118 billion takeover approach from rival drugmaker Pfizer two months ago.
Jul 31, 2014, 12:26 PM IST
SEBI orders close scrutiny of AstraZeneca India delisting
Last week, the company had informed that shareholders through postal ballot have given their go-ahead to a delisting proposal.
Jun 24, 2014, 22:44 PM IST
Essar Oil, AstraZeneca gain on delisting plans
Shares of Ruias-led Essar group firm Essar Oil and that of Indian unit of global pharma giant AstraZeneca surged Monday on the back of delisting plans of the two companies.
Jun 23, 2014, 13:14 PM IST
Drugmaker Shire rejects 27 bn pound bid from US giant AbbVie
Shire Pharmaceuticals rejected Friday a £27-billion informal bid from US giant AbbVie, arguing that it "fundamentally" undervalued the group, in the latest blockbuster deal to hit the global drugs sector.
Jun 20, 2014, 15:30 PM IST
